Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Oct 10;103(41):15142-7.
doi: 10.1073/pnas.0602622103. Epub 2006 Sep 28.

CD8+ regulatory T cells generated by neonatal recognition of peripheral self-antigen

Affiliations

CD8+ regulatory T cells generated by neonatal recognition of peripheral self-antigen

Roland Reibke et al. Proc Natl Acad Sci U S A. .

Abstract

In comparison with CD4+ regulatory T cells, the generation and function of immunomodulatory CD8+T cells is less well defined. Here we describe the existence of regulatory anti-Kb-specific CD8+ T cells that are rendered tolerant during neonatal life via antigen contact exclusively on keratinocytes. These regulatory T cells maintain tolerance during adulthood as they prevent Kb-specific graft rejection by naïve CD8+ T cells. Third-party immune responses remain unaffected. Up-regulation of TGF-beta1 and granzyme B in the regulatory CD8+ T cell population suggests the involvement of these molecules in common suppressive pathways shared with CD4+ regulatory T cells. In summary, CD8+ regulatory T cells can be induced extrathymically through antigen contact on neonatally accessible parenchymal cells and maintain tolerance throughout adult life.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1.
Fig. 1.
Keratinocytes establish long-lived CD8+ T cell tolerance during the neonatal phase in the absence of CD4+ T cells. Shown is the acceptance of Kb-positive skin grafts on tolerant mice. Tx Des-TCR × 2.4KerIV-Kb.Rag-2−/− (n = 9; ■) and Tx Des-TCR.Rag2−/− (n = 6; ×) mice were grafted with C57BL/6 tail skin on their lateral thoracic wall. The transplants were monitored for 30 days. Results were confirmed in three independent experiments.
Fig. 2.
Fig. 2.
Regulation of naïve Des-TCR+ CD8+ T cells in tolerant mice. Acceptance of Kb-positive C57BL/6 skin grafts on Tx Des-TCR × 2.4KerIV-Kb.Rag-2−/− (n = 5; ■) but not on Tx Leish-TCR × 2.4KerIV-Kb.Rag-2−/− (n = 4; ×) mice after i.v. transfer of 3 × 105 spleen cells from naïve Des-TCR.Rag2−/− mice. The transplants were followed up for 30 days.
Fig. 3.
Fig. 3.
Tolerant T cells do not inhibit lymphopenia-induced division of naïve Des-TCR+ CD8+ T cells. A total of 3 × 105 CFSE-labeled spleen cells from naïve Des-TCR.Rag2−/− mice were transferred i.v. into Tx Des-TCR × 2.4KerIV-Kb.Rag-2−/− mice (a) and Tx Leish-TCR × 2.4KerIV-Kb.Rag-2−/− mice (b). After 4 days, total lymph node cells pooled from two or three individual mice were analyzed by flow cytometry for CFSE-positive cells after gating on Des-TCR+ CD8+ T cells. The filled peak indicates the staining intensity of undivided cells. Representative data from three independent experiments are shown.
Fig. 4.
Fig. 4.
Third-party immune reactivity remains intact within the Kb-tolerant mice. Tx Des-TCR × 2.4KerIV-Kb.Rag-2−/− and Tx Leish-TCR × 2.4KerIV-Kb.Rag-2−/− mice received i.v. a mixture of naïve CD8 T cells from TCR-transgenic Rag1−/− mice reacting against Tag and from Des-TCR.Rag2−/− mice (3 × 105 spleen cells from each donor). All mice were challenged s.c. with a Tag-transfected P815 tumor (P815.Tag.Kk.B7). Then, after rejection of this tumor was seen in all animals, the P815.Kb.B7 tumor was inoculated into the same mice. Tumor growth was observed in five of five of the Tx Des-TCR × 2.4KerIV-Kb.Rag-2−/− mice but in none of the Tx Leish-TCR × 2.4KerIV-Kb.Rag-2−/− mice.

References

    1. Kappler JW, Roehm N, Marrack P. Cell. 1987;49:273–280. - PubMed
    1. Ramsdell F, Fowlkes BJ. Science. 1990;248:1342–1348. - PubMed
    1. Hori S, Nomura T, Sakaguchi S. Science. 2003;299:1057–1061. - PubMed
    1. Graca L, Chen TC, Le Moine A, Cobbold SP, Howie D, Waldmann H. Trends Immunol. 2005;26:130–135. - PubMed
    1. Modigliani Y, Thomas-Vaslin V, Bandeira A, Coltey M, Le Douarin NM, Coutinho A, Salaun Z. Proc Natl Acad Sci USA. 1995;92:7555–7559. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources